These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 8777130)
1. A pitfall in the use of the Altman nomogram for power estimation. Evans MJ; Harrison CA; Mapleson WW Br J Anaesth; 1996 Feb; 76(2):334. PubMed ID: 8777130 [No Abstract] [Full Text] [Related]
2. Design and analysis of non-inferiority mortality trials in oncology. Carroll K; Milsted B; Lewis JA Stat Med; 2004 Sep; 23(17):2771-4; author reply 2774-8. PubMed ID: 15316946 [No Abstract] [Full Text] [Related]
3. Is human immunodeficiency virus sexual risk prevention intervention effective? Solomon B; McGuinn L; Hoerlein M; Basco W; Rowe P; Lehmann H Arch Pediatr Adolesc Med; 2001 Oct; 155(10):1127-30. PubMed ID: 11576007 [No Abstract] [Full Text] [Related]
4. Multiple comparisons to both a negative and a positive control. Hasler M Pharm Stat; 2012; 11(1):74-81. PubMed ID: 22232049 [TBL] [Abstract][Full Text] [Related]
5. Optimal design of clinical trials comparing several treatments with a control. Marschner IC Pharm Stat; 2007; 6(1):23-33. PubMed ID: 17323312 [TBL] [Abstract][Full Text] [Related]
6. Assessing departure from dose linearity under a repeated measures incomplete block design. Cheng B; Chow SC Pharm Stat; 2011; 10(4):357-62. PubMed ID: 21104786 [TBL] [Abstract][Full Text] [Related]
7. Avoiding ambiguity with the Type I error rate in noninferiority trials. Kang SH J Biopharm Stat; 2016; 26(3):452-65. PubMed ID: 26252624 [TBL] [Abstract][Full Text] [Related]
8. Test for the consistency of noninferiority from multiple clinical trials. Yan X; Wang MC; Su X J Biopharm Stat; 2007; 17(2):265-78. PubMed ID: 17365223 [TBL] [Abstract][Full Text] [Related]
9. Multiple-arm superiority and non-inferiority designs with various endpoints. Chang M Pharm Stat; 2007; 6(1):43-52. PubMed ID: 17323311 [TBL] [Abstract][Full Text] [Related]
10. Assessing non-inferiority of a new treatment in a three-arm clinical trial including a placebo. Pigeot I; Schäfer J; Röhmel J; Hauschke D Stat Med; 2003 Mar; 22(6):883-99. PubMed ID: 12627407 [TBL] [Abstract][Full Text] [Related]
11. Do statistics ever lie? Burkhart SS Arthroscopy; 2002 Oct; 18(8):823. PubMed ID: 12368776 [No Abstract] [Full Text] [Related]
13. A step-down procedure for multiple tests of treatment versus control in each of several groups. Cheung SH; Holland B Stat Med; 1994 Nov; 13(21):2261-7. PubMed ID: 7846424 [TBL] [Abstract][Full Text] [Related]
14. A powerful test for Balaam's design. Mori J; Kano Y Pharm Stat; 2015; 14(6):464-70. PubMed ID: 26214841 [TBL] [Abstract][Full Text] [Related]
15. Testing non-inferiority and superiority for two endpoints for several treatments with a control. Lawrence J Pharm Stat; 2011; 10(4):318-24. PubMed ID: 20949636 [TBL] [Abstract][Full Text] [Related]
16. Modified Haybittle-Peto group sequential designs for testing superiority and non-inferiority hypotheses in clinical trials. Lai TL; Shih MC; Zhu G Stat Med; 2006 Apr; 25(7):1149-67. PubMed ID: 16189814 [TBL] [Abstract][Full Text] [Related]
17. Simultaneous test for superiority and noninferiority hypotheses in active-controlled clinical trials. Tsong Y; Zhang J J Biopharm Stat; 2007; 17(2):247-57. PubMed ID: 17365221 [TBL] [Abstract][Full Text] [Related]
18. New tests for null hypothesis of non unity ratio of proportions. Koti KM J Biopharm Stat; 2007; 17(2):229-45. PubMed ID: 17365220 [TBL] [Abstract][Full Text] [Related]